Early adenosine receptor activation ameliorates spinal cord reperfusion injury

T. Brett Reece, Curtis G. Tribble, David O. Okonkwo, Jonathon D. Davis, Thomas S. Maxey, Leo M. Gazoni, Joel Linden, Irving L. Kron, John A. Kern

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

OBJECTIVES: Adenosine receptor activation at reperfusion has been shown to ameliorate ischemia-reperfusion injury of the spinal cord, but the effects of therapy given in response to ischemic injury are unknown. We hypothesized that adenosine receptor activation with ATL-146e would produce similar protection from ischemic spinal cord injury, whether given at reperfusion or in a delayed fashion. METHODS: Twenty-two New Zealand white rabbits were divided into three groups. All three groups, including the ischemia-reperfusion group (IR, n = 8), underwent 45 min of infrarenal aortic occlusion. The early treatment group (early, n = 8) received 0.06 μg/kg/min of ATL-146e for 3 h beginning 10 min prior to reperfusion. The delayed treatment group (delayed, n = 6) received ATL-146e starting 1 h after reperfusion. After 48 h, hind limb function was graded using the Tarlov score. Finally, lumbar spinal cord neuronal cytoarchitecture was evaluated. RESULTS: Hemodynamic parameters were similar among the groups. Hind limb function at 48 h was significantly better in the early group (3.5 ± 1.0) compared to the IR group (0.625 ± 0.5, P ≤ 0.01). There was a trend towards better hind limb function in the early group compared to the delayed group (2.4 ± 1.1, P = 0.08). Hind limb function was similar between delayed and IR groups. Hematoxylin-eosin spinal cord sections demonstrated preservation of viable motor neurons in the early group compared to the delayed and IR groups. CONCLUSIONS: Early therapy with ATL-146e provided better protection in this study; therefore, therapy should not be delayed until there is evidence of ischemic neurological deficit. This study suggests that adenosine receptor activation is most effective as a preventive strategy at reperfusion for optimal protection in spinal cord ischemia-reperfusion injury.

Original languageEnglish (US)
Pages (from-to)363-367
Number of pages5
JournalJournal of Cardiovascular Medicine
Volume9
Issue number4
DOIs
StatePublished - Apr 1 2008
Externally publishedYes

Fingerprint

Purinergic P1 Receptors
Reperfusion Injury
Spinal Cord Injuries
Reperfusion
Spinal Cord
Extremities
Spinal Cord Ischemia
Motor Neurons
Therapeutics
Hematoxylin
Eosine Yellowish-(YS)
Secondary Prevention
Ischemia
Hemodynamics
Rabbits
ATL 146e
Wounds and Injuries

Keywords

  • Adenosine
  • Paraplegia
  • Spinal cord ischemia
  • Vascular surgery

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Reece, T. B., Tribble, C. G., Okonkwo, D. O., Davis, J. D., Maxey, T. S., Gazoni, L. M., ... Kern, J. A. (2008). Early adenosine receptor activation ameliorates spinal cord reperfusion injury. Journal of Cardiovascular Medicine, 9(4), 363-367. https://doi.org/10.2459/JCM.0b013e3282eee836

Early adenosine receptor activation ameliorates spinal cord reperfusion injury. / Reece, T. Brett; Tribble, Curtis G.; Okonkwo, David O.; Davis, Jonathon D.; Maxey, Thomas S.; Gazoni, Leo M.; Linden, Joel; Kron, Irving L.; Kern, John A.

In: Journal of Cardiovascular Medicine, Vol. 9, No. 4, 01.04.2008, p. 363-367.

Research output: Contribution to journalArticle

Reece, TB, Tribble, CG, Okonkwo, DO, Davis, JD, Maxey, TS, Gazoni, LM, Linden, J, Kron, IL & Kern, JA 2008, 'Early adenosine receptor activation ameliorates spinal cord reperfusion injury', Journal of Cardiovascular Medicine, vol. 9, no. 4, pp. 363-367. https://doi.org/10.2459/JCM.0b013e3282eee836
Reece, T. Brett ; Tribble, Curtis G. ; Okonkwo, David O. ; Davis, Jonathon D. ; Maxey, Thomas S. ; Gazoni, Leo M. ; Linden, Joel ; Kron, Irving L. ; Kern, John A. / Early adenosine receptor activation ameliorates spinal cord reperfusion injury. In: Journal of Cardiovascular Medicine. 2008 ; Vol. 9, No. 4. pp. 363-367.
@article{30592150cf0945058a40c9b2e1b87d07,
title = "Early adenosine receptor activation ameliorates spinal cord reperfusion injury",
abstract = "OBJECTIVES: Adenosine receptor activation at reperfusion has been shown to ameliorate ischemia-reperfusion injury of the spinal cord, but the effects of therapy given in response to ischemic injury are unknown. We hypothesized that adenosine receptor activation with ATL-146e would produce similar protection from ischemic spinal cord injury, whether given at reperfusion or in a delayed fashion. METHODS: Twenty-two New Zealand white rabbits were divided into three groups. All three groups, including the ischemia-reperfusion group (IR, n = 8), underwent 45 min of infrarenal aortic occlusion. The early treatment group (early, n = 8) received 0.06 μg/kg/min of ATL-146e for 3 h beginning 10 min prior to reperfusion. The delayed treatment group (delayed, n = 6) received ATL-146e starting 1 h after reperfusion. After 48 h, hind limb function was graded using the Tarlov score. Finally, lumbar spinal cord neuronal cytoarchitecture was evaluated. RESULTS: Hemodynamic parameters were similar among the groups. Hind limb function at 48 h was significantly better in the early group (3.5 ± 1.0) compared to the IR group (0.625 ± 0.5, P ≤ 0.01). There was a trend towards better hind limb function in the early group compared to the delayed group (2.4 ± 1.1, P = 0.08). Hind limb function was similar between delayed and IR groups. Hematoxylin-eosin spinal cord sections demonstrated preservation of viable motor neurons in the early group compared to the delayed and IR groups. CONCLUSIONS: Early therapy with ATL-146e provided better protection in this study; therefore, therapy should not be delayed until there is evidence of ischemic neurological deficit. This study suggests that adenosine receptor activation is most effective as a preventive strategy at reperfusion for optimal protection in spinal cord ischemia-reperfusion injury.",
keywords = "Adenosine, Paraplegia, Spinal cord ischemia, Vascular surgery",
author = "Reece, {T. Brett} and Tribble, {Curtis G.} and Okonkwo, {David O.} and Davis, {Jonathon D.} and Maxey, {Thomas S.} and Gazoni, {Leo M.} and Joel Linden and Kron, {Irving L.} and Kern, {John A.}",
year = "2008",
month = "4",
day = "1",
doi = "10.2459/JCM.0b013e3282eee836",
language = "English (US)",
volume = "9",
pages = "363--367",
journal = "Journal of Cardiovascular Medicine",
issn = "1558-2027",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Early adenosine receptor activation ameliorates spinal cord reperfusion injury

AU - Reece, T. Brett

AU - Tribble, Curtis G.

AU - Okonkwo, David O.

AU - Davis, Jonathon D.

AU - Maxey, Thomas S.

AU - Gazoni, Leo M.

AU - Linden, Joel

AU - Kron, Irving L.

AU - Kern, John A.

PY - 2008/4/1

Y1 - 2008/4/1

N2 - OBJECTIVES: Adenosine receptor activation at reperfusion has been shown to ameliorate ischemia-reperfusion injury of the spinal cord, but the effects of therapy given in response to ischemic injury are unknown. We hypothesized that adenosine receptor activation with ATL-146e would produce similar protection from ischemic spinal cord injury, whether given at reperfusion or in a delayed fashion. METHODS: Twenty-two New Zealand white rabbits were divided into three groups. All three groups, including the ischemia-reperfusion group (IR, n = 8), underwent 45 min of infrarenal aortic occlusion. The early treatment group (early, n = 8) received 0.06 μg/kg/min of ATL-146e for 3 h beginning 10 min prior to reperfusion. The delayed treatment group (delayed, n = 6) received ATL-146e starting 1 h after reperfusion. After 48 h, hind limb function was graded using the Tarlov score. Finally, lumbar spinal cord neuronal cytoarchitecture was evaluated. RESULTS: Hemodynamic parameters were similar among the groups. Hind limb function at 48 h was significantly better in the early group (3.5 ± 1.0) compared to the IR group (0.625 ± 0.5, P ≤ 0.01). There was a trend towards better hind limb function in the early group compared to the delayed group (2.4 ± 1.1, P = 0.08). Hind limb function was similar between delayed and IR groups. Hematoxylin-eosin spinal cord sections demonstrated preservation of viable motor neurons in the early group compared to the delayed and IR groups. CONCLUSIONS: Early therapy with ATL-146e provided better protection in this study; therefore, therapy should not be delayed until there is evidence of ischemic neurological deficit. This study suggests that adenosine receptor activation is most effective as a preventive strategy at reperfusion for optimal protection in spinal cord ischemia-reperfusion injury.

AB - OBJECTIVES: Adenosine receptor activation at reperfusion has been shown to ameliorate ischemia-reperfusion injury of the spinal cord, but the effects of therapy given in response to ischemic injury are unknown. We hypothesized that adenosine receptor activation with ATL-146e would produce similar protection from ischemic spinal cord injury, whether given at reperfusion or in a delayed fashion. METHODS: Twenty-two New Zealand white rabbits were divided into three groups. All three groups, including the ischemia-reperfusion group (IR, n = 8), underwent 45 min of infrarenal aortic occlusion. The early treatment group (early, n = 8) received 0.06 μg/kg/min of ATL-146e for 3 h beginning 10 min prior to reperfusion. The delayed treatment group (delayed, n = 6) received ATL-146e starting 1 h after reperfusion. After 48 h, hind limb function was graded using the Tarlov score. Finally, lumbar spinal cord neuronal cytoarchitecture was evaluated. RESULTS: Hemodynamic parameters were similar among the groups. Hind limb function at 48 h was significantly better in the early group (3.5 ± 1.0) compared to the IR group (0.625 ± 0.5, P ≤ 0.01). There was a trend towards better hind limb function in the early group compared to the delayed group (2.4 ± 1.1, P = 0.08). Hind limb function was similar between delayed and IR groups. Hematoxylin-eosin spinal cord sections demonstrated preservation of viable motor neurons in the early group compared to the delayed and IR groups. CONCLUSIONS: Early therapy with ATL-146e provided better protection in this study; therefore, therapy should not be delayed until there is evidence of ischemic neurological deficit. This study suggests that adenosine receptor activation is most effective as a preventive strategy at reperfusion for optimal protection in spinal cord ischemia-reperfusion injury.

KW - Adenosine

KW - Paraplegia

KW - Spinal cord ischemia

KW - Vascular surgery

UR - http://www.scopus.com/inward/record.url?scp=40649116725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40649116725&partnerID=8YFLogxK

U2 - 10.2459/JCM.0b013e3282eee836

DO - 10.2459/JCM.0b013e3282eee836

M3 - Article

C2 - 18334890

AN - SCOPUS:40649116725

VL - 9

SP - 363

EP - 367

JO - Journal of Cardiovascular Medicine

JF - Journal of Cardiovascular Medicine

SN - 1558-2027

IS - 4

ER -